Bankruptcy is the newest “Exit” strategy
July 24th, 2009
No comments
The ongoing economic crisis had made bankruptcies; one of the newest “EXIT” strategies for many emerging small cap healthcare companies. The companies most at risk have less than 6 months of cash and usually no “definitive” clinical data in the near future. It has been stated that 25% of emerging small cap healthcare companies (usually biotechs) fall into this category of teetering on the edge. Is one of the issues the plethora of “me to” platforms?
Categories: Biotechnology, Healthcare, Independent Equity Research
